<DOC>
	<DOCNO>NCT00278941</DOCNO>
	<brief_summary>The purpose study determine safety &amp; efficacy SEROQUEL SR™ treatment major depressive disorder compare placebo &amp; evaluate quality sleep , overall quality life , effect , , anxiety satisfaction PLEASE NOTE : Seroquel SR Seroquel XR refer formulation . The SR designation change XR consultation FDA .</brief_summary>
	<brief_title>Quetiapine Fumarate Monotherapy Maintenance Treatment Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Documented clinical diagnosis accord DSMIV ( Diagnostic Statistical Manual Mental Disorders , 4th edition , text revision ) meeting criterion 296.2x Major Depressive Disorder , Single Episode , 296.3x Major Depressive Disorder , Patients DSMIV Axis I disorder MDD w/in 6 month enrollment , Patients diagnosis DSMIV Axis II disorder major impact patient current psychiatric status . Patients whose current episode depression &gt; 12 month &lt; 4 week enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Seroquel SR™</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>